Regeneron Pharmaceuticals Inc

LSE:0R2M

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0R2M's stock price target?

Price Target

847.33 USD

According to Wall Street analysts, the average 1-year price target for 0R2M is 847.33 USD with a low forecast of 648.57 USD and a high forecast of 1 083.44 USD.

What is the Revenue forecast for Regeneron Pharmaceuticals Inc?

Projected CAGR

5%

Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 8 years is 5%.

What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?

Projected CAGR

5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 8 years is 5%.

What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?

Projected CAGR

11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 8 years is 11%.

What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?

Projected CAGR

15%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 22%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Regeneron Pharmaceuticals Inc?

Projected CAGR

8%

Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 8 years is 8%.